HAUPPAUGE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2025. First quarter sales decreased from $3,254,944 in 2024 to $2,481,127 in 2025, with net income decreasing from $925,442 ($0.20 per share) to $560,895 ($0.12 per share). Donna Vigilante, President of United-Guardian, stated, “We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant ...

Financial Data and Key Metrics Changes - Total reported revenue for Q1 2025 was $693 million, down from $711 million in the prior year, primarily due to lower COVID and donor screening revenue [18] - Excluding COVID and donor screening, the company achieved a mid single-digit revenue growth of 6% [18] - Adjusted EBITDA margin improved by 450 basis points year over year to 23%, with adjusted diluted EPS increasing by 68% to $0.74 [24][25] Business Line Data and Key Metrics Changes - Labs business, accounting for 54% of total revenue, grew by 7%, driven by clinical chemistry and immunoassay testing [10] - Immunohematology business grew by 4%, maintaining its global leadership position [10] - Point of Care business represented 25% of Q1 revenue and grew by 8% excluding COVID, with strong flu sales leading to an 18% year-over-year growth [10] - Molecular Diagnostics business grew by 11% excluding COVID, with ongoing clinical trials for the Savanna respiratory panel [11] Market Data and Key Metrics Changes - Revenue from the "Other" region (Japan, Asia Pacific, Latin America) grew by 12%, driven by a 17% increase in Labs revenue [19] - North America revenue declined by 6% due to lower COVID revenue and donor screening wind down, but grew by 5% when excluding these factors [19] - Europe, Middle East, and Africa grew by 9%, while China revenue remained flat, primarily due to order timing and decreased Triage revenue [20] Company Strategy and Development Direction - The company is focused on a narrow set of strategic initiatives, including increasing platform content and utility, expanding margins, and enhancing commercial execution [11] - Plans to realize $100 million in annualized cost savings, with $50 million expected in the first half of 2025 [12] - The company aims to maintain its manufacturing footprint and continue investing in U.S.-based manufacturing and R&D [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and operational discipline, highlighting strong Q1 results and ongoing initiatives [9] - The company anticipates potential tariff impacts of $30 million to $40 million in 2025 but believes mitigation plans will offset these impacts [15] - Full-year 2025 financial guidance remains unchanged, with expectations for total reported revenue between $2.6 billion and $2.81 billion [27] Other Important Information - The company has invested nearly $1 billion in U.S.-based manufacturing and R&D over the past three years [13] - Adjusted free cash flow for Q1 2025 was $47 million, representing 29% of adjusted EBITDA [26] - The company plans to refinance its debt in the second half of 2025 or early 2026, depending on market conditions [31] Q&A Session Summary Question: Can you elaborate on the tariff impact and pricing actions? - Management indicated that selective pricing actions are being considered to offset tariff impacts, but competitive market conditions must be taken into account [36][37] Question: Will tariff impacts affect long-term manufacturing plans? - Management does not expect changes to the overall manufacturing footprint, emphasizing the importance of their global manufacturing network [38] Question: How confident is the company in mitigating tariff impacts? - Management expressed confidence in fully mitigating tariff impacts through various actions, including cost reductions and realigning inventories [43] Question: What underpins the confidence in China's growth rate? - Confidence in mid to high single-digit growth in China is based on strong performance in labs and immunohematology, despite some softness in Triage sales [49] Question: What is the status of the Savanna program? - The company is focused on completing the RBP4x submission to the FDA and is not speculating on outcomes beyond that [45][61] Question: How is the respiratory sales performance impacting guidance? - Management expects to maintain the guidance range for COVID revenue despite a decline, as flu sales have been strong [56][58]

Financial Data and Key Metrics Changes - Orders increased by nearly 22% in the quarter, resulting in a record backlog of $932 million [15] - Sales grew by 6.6% in the quarter, with all three segments contributing to the increase [15] - Adjusted EBIT margins were at 18%, with incremental margins on sales growth at 56%, leading to adjusted earnings per share of $1.35, a 24% increase year-over-year [15][21] Business Segment Data and Key Metrics Changes - **Aerospace and Defense**: Orders were up 5% with nearly 8% sales growth, driven by commercial aerospace and Navy orders. Adjusted EBIT margins increased by 400 basis points, with EBIT dollars up 28% due to favorable pricing and mix [16][18] - **Utility Solutions Group**: Orders grew nearly 17%, with sales up 4%. Doble experienced 5% sales growth, while NRG's sales were flat. Adjusted EBIT margins improved to 23%, up 290 basis points year-over-year [17][19] - **Test Business**: Orders surged by 75% compared to last year, with sales up 9%. Margins improved to 12.4%, benefiting from volume leverage and price increases [19][20] Market Data and Key Metrics Changes - The aerospace market shows fundamental demand for additional commercial and defense aircraft, with expectations for continued growth despite recent moderation in order rates [8][9] - The utility market is experiencing a favorable business cycle, driven by increased electricity demand and aging infrastructure [11][12] - The test business is recovering, with strong activity in EMC testing, healthcare, and industrial markets [13][14] Company Strategy and Development Direction - The company completed a major acquisition of SMMP, rebranding it as ESCO Maritime Solutions, which is expected to enhance margin and growth profiles [10][24] - The strategic planning process indicates a focus on delivering above-market growth by assessing end markets and strategies [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic uncertainties and geopolitical risks, highlighting strong underlying business conditions [4][5] - The long-term outlook for aerospace and defense remains positive, with expectations for continued growth despite short-term challenges [7][9] - The company anticipates growth in the utility sector due to increasing electricity demand and the importance of renewable technologies [12] Other Important Information - The company expects sales growth of 6% to 8% for the year, with adjusted earnings per share guidance increased to a range of $5.65 to $5.85 [23][24] - The acquisition is projected to contribute adjusted earnings per share in the range of $0.20 to $0.30 [23] Q&A Session Summary Question: Update on the sale of VACCO - Management indicated ongoing interest in the sale process, with a decision expected by May [28] Question: Performance of the underlying business - The business has stabilized with improved performance compared to last year, although margins remain lower than other segments [30] Question: Clarification on tariff impacts - The estimated tariff impact of $2 million to $4 million is a net number, factoring in mitigation efforts [32][34] Question: Cash generation from Maritime Solutions - Management expects strong cash flow benefits from the Maritime acquisition, with ongoing assessments as integration progresses [40] Question: Thoughts on the 2025 and 2026 budget for shipbuilding - Management is optimistic about the shipbuilding budget, noting strong visibility and progress in programs [42][43] Question: Commercial aircraft orders moderation - Management noted a slight moderation in orders due to inventory management but remains confident in future growth [68] Question: Status of Department of Defense programs - Programs related to submarines and Navy initiatives are prioritized, with a positive order flow expected [70]

Central Garden & Pet Company (CENT) Q2 2025 Earnings Call May 07, 2025 04:30 PM ET Company Participants Friederike Edelmann - VP, IRNiko Lahanas - CEOBrad Smith - Chief Financial OfficerBill Chappell - Managing DirectorJohn Hanson - President, Pet Consumer ProductsJ.D. Walker - President, Garden Consumer ProductsPeter Lukas - Director Conference Call Participants Bradley Thomas - Managing Director & Equity Research AnalystJim Chartier - AnalystBrian McNamara - MD & Senior Analyst - ConsumerShovana Chowdhury ...

BorgWarner (BWA) Q1 2025 Earnings Call May 07, 2025 09:30 AM ET Speaker0 Good morning. My name is Wyatt, and I will be your conference specialist. At this time, I would like to welcome everyone to the BorgWarner twenty twenty five First Quarter Results Conference Call. All participants will be in listen only mode. I would now like to turn the call over to Patrick Nolan, Vice President of Investor Relations. Mr. Nolan, you may begin your conference. Speaker1 Thank you, Wyatt. Good morning, everyone. Thank yo ...

Steven Madden (SHOO) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Company Participants Danielle McCoy - Vice President of Corporate Development & Investor RelationsEdward Rosenfeld - Chairman & CEOZine Mazouzi - CFOJay Sole - Managing DirectorLaura Champine - Director of ResearchTom Nikic - Managing Director, Equity ResearchDana Telsey - CEO and Chief Research OfficerCorey Tarlowe - SVP - Equity Research Conference Call Participants Kelly Crago - AnalystAnna Andreeva - Managing Director & Senior Research ...

RumbleON (RMBL) Q1 2025 Earnings Call May 07, 2025 09:00 AM ET Speaker0 Greetings, and welcome to the RumbleOn, Inc. First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Olliot Wagner, Vice President of Finance. Thank you. Please go ahead. Speaker1 Thank you, operator. Good morn ...

V i e w p o i n t | 02 May 2025 13:06:59 ET │ 23 pages US Economics Weekly Three stages of tariff impacts CITI'S TAKE Market optimism is building in anticipation of upcoming trade deals and as hard data have not yet weakened in line with much softer survey data. Real GDP contracted a modest 0.3% in Q1 on strong imports, while private domestic demand rose a strong 3.0%. April employment grew by 177k jobs, while the unemployment rate was unchanged at 4.2%. But we would caution that recent data have not reflec ...

Koninklijke Philips NV PHG reported first-quarter 2025 adjusted earnings per share of 26 cents (or 0.25 euros), beating the consensus of 20 cents.The Dutch healthcare technology group reported quarterly sales of $4.31 billion (4.09 billion euros), beating the consensus of $4.10 billion.Comparable sales decreased by 2%, including a double-digit decline in China.Diagnosis & Treatment comparable sales decreased by 4%, due to a double-digit decline in China and on the back of a high comparison base in prior yea ...

Mueller Water Products (MWA) Q2 2025 Earnings Call May 06, 2025 10:00 AM ET Speaker0 Today's conference is being recorded. If you have any objections, you may disconnect at this time. It is now my pleasure to turn the call over to Mr. Whit Kincaid. Sir, you may begin. Speaker1 Good morning, everyone. Thank you for joining us for Mueller Water Products second quarter conference call. Yesterday afternoon, we issued our press release reporting results of operations for the quarter ended 03/31/2025. A copy of t ...